Biotech Executive Meenu Chhabra Karson joins Bedford Transearch Advisory Board
Denmark’s Xellia has made another stride in its work to restore the former Boehringer Ingelheim plant in Ohio into a sterile drug producing facility that the FDA will again approve. It has also brought on 90 employees as it prepares to reopen the plant for production in 2018.
Bedford recalls P-P-P(COBAL) 30-1-5/mL due to Lack of assurance sterility
Bedford recalls Testosterone Cypionate due to Lack of assurance of sterility
The huge former Ben Venue injectables manufacturing plant in Ohio that became the center of controversy over drug shortages a few years ago remains off line, and the company that now owns the site reiterated this week that it has no plans to resume making products there.
Top Class I drug recallers
Hikma Profits Soften as Shortages of Doxycycline are Resolved
Federal judge approves consent decree with Ben Venue Laboratories